Nanjing BioPoint Diagnostic Technology
PrivateLast Round
Seed
Apr 14, 2014
Total Funding Raised
$240,000
Company Overview
Nanjing BioPoint Diagnostic Technology operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was a Seed round in April 2014.
Nanjing BioPoint Diagnostic Technology is a medical technology company that develops and manufactures point-of-care diagnostic tests and devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing BioPoint Diagnostic Technology Comparables
Compare Nanjing BioPoint Diagnostic Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Premier Medical Corporation | 80% | |
| Diagnostics For All | 80% | |
| Sedia Biosciences Corporation | 79% |
For institutional investors. Book with your work email.
Nanjing BioPoint Diagnostic Technology Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nanjing BioPoint Diagnostic Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nanjing Municipal Government | Grant |
| Beijing Guominxinhe Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2014
Seed round with investors including Beijing Guominxinhe Group and Burnet Institute.
For institutional investors. Book with your work email.
Nanjing BioPoint Diagnostic Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanjing BioPoint Diagnostic Technology's valuation, stock price, and market status.
Is Nanjing BioPoint Diagnostic Technology a public or private company?
Nanjing BioPoint Diagnostic Technology is a private company.
What is the current stock price of Nanjing BioPoint Diagnostic Technology?
Nanjing BioPoint Diagnostic Technology is a private company, so its shares have no public market price. Caplight tracks Nanjing BioPoint Diagnostic Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanjing BioPoint Diagnostic Technology worth (valuation)?
Valuation information for Nanjing BioPoint Diagnostic Technology is not publicly available.
Can I buy Nanjing BioPoint Diagnostic Technology stock?
Nanjing BioPoint Diagnostic Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanjing BioPoint Diagnostic Technology's last funding round?
Nanjing BioPoint Diagnostic Technology's most recent funding round was Seed on April 14, 2014.
Who are the main investors in Nanjing BioPoint Diagnostic Technology?
Key investors in Nanjing BioPoint Diagnostic Technology include Nanjing Municipal Government, Beijing Guominxinhe Group.
Will Nanjing BioPoint Diagnostic Technology IPO soon?
No public IPO plans have been announced for Nanjing BioPoint Diagnostic Technology.
How can I track Nanjing BioPoint Diagnostic Technology secondary market activity?
Caplight tracks bids, offers, and trades in Nanjing BioPoint Diagnostic Technology's shares on secondary markets.